ArticleAnalytical and bioanalytical chemistry2026
An inertial-acoustofluidic platform for bioanalysis: concurrent, high-precision, high-throughput separation of cells and bacteria.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Efficient separation of cancer cells from whole blood is vital for early cancer diagnosis. However, disease progression often causes complications that reduce survival, such as cholangitis in liver cancer due to bile-duct compression, with Escherichia coli (E. coli) and Klebsiella as common pathogens. To address this, we developed a sheathless microfluidic sorter that integrates inertial focusing with surface acoustic wave (SAW) manipulation to simultaneously isolate cancer cells and bacteria. Specifically, we introduce a label-free, SAW-driven microfluidic platform that couples passive inertial focusing with active SAW manipulation to enable concurrent separation of cancer cells and bacteria; Cr/Au interdigital transducers (IDTs) are patterned on a 128° Y-cut LiNbO₃ substrate. The system first employs a contraction-expansion microchannel to achieve preliminary separation. Larger particles are then deflected by a slanted interdigital transducer (S-IDT), improving bacterial sorting purity. Small particles are enriched at the first outlet (purity > 96%), and the remaining targets are further refined by a focusing interdigital transducer (F-IDT). Tests with polystyrene (PS) particles achieved >96% purity, and in clinical samples, sorting efficiency and purity exceeded 93% for HepG2 cells and E. coli, with HepG2 viability above 94%. This compact platform unifies active and passive mechanisms, offering promise for early diagnosis and real-time monitoring of complications.
Indexed as
Identifiers
41498815What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.